About Passage Bio (PASG)
Passage Bio Inc is a preclinical stage genetic medicines company. The Company is focused on developing transformative therapies for rare, monogenic central nervous system (CNS). The Company is developing a portfolio of six life transforming AAV-deliv... Read more
- USD1.34
- USD1.38
- USD1.30
- USD1.79
- 3.10%
- --
- 41.06k
- 119.59k
- 81M
- 0.58
- 35.40%
Stock News
2 hours ago
Here's how much money you'd have lost if you invested $1,000 in Peloton when it went public
CNBC
2 hours ago
SiriusXM to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
Yahoo
2 hours ago
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo
2 hours ago
Skittles is giving away a 1-year stay in an NYC micro-apartment that usually rents for $3,500/month: Take a look inside
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
